News | July 14, 2008

Epocrates Drug, Formulary Application Available for iPhone, iPod

July 15, 2008 - Epocrates Inc. announced that its mobile drug and formulary reference, reportedly used by more than 500,000 healthcare professionals, can be downloaded free for the iPhone and iPod touch from the Apple App Store after Epocrates registration.

In addition, for the first time, the Epocrates Rx mobile application will feature pill pictures and a drug identification tool, providing more visual cues and resources for today's busy physicians. With enhanced functionality, clinicians can show their patients pictures of a newly prescribed drug, or identify a patient's existing medication with a physical description (e.g., round, blue and scored) when the name cannot be recalled.

"I believe Epocrates on the iPhone is an essential tool for the medical community - it is the one native application most healthcare professionals cannot live without," said Dr. Michael Salesin, Wayne State University School of Medicine. "Many of my colleagues have been waiting for the Epocrates application before purchasing the iPhone. I guarantee it's going to be the first download on many devices, and immediately put to use with patients."

Epocrates software is used by clinicians worldwide to reference a host of drug information, such as dosing, interactions and health plan coverage.

The Epocrates free application is available from Apple's App Store on iPhone and iPod touch or at www.itunes.com/appstore.

For more information: www.epocrates.com/company

Related Content

Pfizer Announces Positive Topline Results from Phase 3 ATTR-ACT Study
News | Pharmaceuticals | April 06, 2018
Pfizer Inc. announced that the Tafamidis Phase 3 Transthyretin Cardiomyopathy (ATTR-ACT) study met its primary endpoint...
Humanetics Presents Data on Drug to Protect Cardiac Cells From Space-Like Radiation

Photo from NASA

News | Pharmaceuticals | February 01, 2018
February 1, 2018 –Humanetics Corporation (Humanetics) has recently completed two research studies funded by the Natio
Xarelto Significantly Reduces Major Cardioavascular Events in Stable CAD and PAD Patients
News | Pharmaceuticals | October 18, 2017
October 18, 2017 — Results from the pivotal Phase 3 COMPASS study found that the...
News | Pharmaceuticals | October 04, 2017
October 4, 2017 — MyoKardia Inc.
News | Pharmaceuticals | September 12, 2017
September 12, 2017 — Inclisiran lowers low-density lipoprotein (LDL, or “bad”) cholesterol for up to one year in pati
Merck Announces Results of REVEAL Outcomes Study of Anacetrapib
News | Pharmaceuticals | September 11, 2017
Merck and researchers in the Clinical Trial Service Unit at the University of Oxford announced the publication and...
Statins Associated With Improved Heart Structure and Function
News | Pharmaceuticals | May 26, 2017
Statins are associated with improved heart structure and function, according to research presented at EuroCMR 2017, May...
Feature | Pharmaceuticals | May 16, 2017
May 16, 2017 – Results of a groundbreaking clinical trial demonstrate the effectiveness of a novel, fast-acting nasal
Prescribing Patterns Change Following Direct Marketing Restrictions
News | Pharmaceuticals | May 05, 2017
A study of how policies restricting pharmaceutical promotion to physicians affect medication prescribing found...
EBBINGHAUS study, evolocumab, repatha, statin therapy, cognitive issues, ACC.17 study
News | Pharmaceuticals | April 03, 2017
There is no evidence that adding a new cholesterol-lowering drug to treatment with a statin causes memory loss or other...
Overlay Init